Abstract
The human c-erbB-2 oncogene is homologous to the ratneu oncogene, both encoding transmembrane growth factor receptors. Overexpression and point mutations in the transmembrane domain of the encoded proteins in both cases have been implicated in cell transformation and carcinogenesis. In the case of theneu protein, it has been proposed that these effects are mediated by conformational preferences for anα-helix in the transmembrane domain, which facilitates receptor dimerization, an important step in the signal transduction process. To examine whether this is the case for c-erbB-2 as well, we have used conformational energy analysis to determine the preferred three-dimensional structures for the transmembrane domain of the c-erbB-2 protein from residues 650 to 668 with Val (nontransforming) and Glu (transforming) at position 659. The global minimum energy conformation for the Val-659 peptide from the normal, nontransforming protein was found to contain several bends, whereas the global minimum energy conformation for Glu-659 peptide from the mutant, transforming protein was found to beα-helical. Thus, the difference in conformational preferences for these transmembrane domains may explain the difference in transforming ability of these proteins. The presence of higher-energyα-helical conformations for the transmembrane domain from the normal Val-659 protein may provide an explanation for the presence of a transforming effect from overexpression of c-erbB-2. In addition, docking of the oncogenic sequences in theirα-helical and bend conformations shows that the all-α-helical dimer is clearly favored energetically over the bend dimer.
Similar content being viewed by others
References
Bargmann, C. I., Hung, M.-C., and Weinberg, R. A. (1986).Nature 319, 226–230.
Ben-Levy, R. E., Peles, E., Goldman-Michael, R., and Yarden, Y. (1992).J. Biol. Chem. 267, 17304–17313.
Brandt-Rauf, P. W., Pincus, M. R., and Chen, J. (1989).J. Protein Chem. 8, 749–756.
Brandt-Rauf, P. W., Rackovsky, S., and Pincus, M. R. (1990).Proc. Natl. Acad. Sci. USA 87, 8660–8664.
Brandt-Rauf, P. W., DeVivo, I., Dykes, D. C., and Pincus, M. R. (1992).J. Biomol. Struct. Dyn. 10, 253–264.
Brandt-Rauf, P. W., Monaco, R., and Pincus, M. R. (1994a).J. Protein Chem. 13, 227–231.
Brandt-Rauf, P. W., Pincus, M. R., and Carney, W. P. (1994b).Crit. Rev. Oncogen.,5, 313–329.
Carpenter, C. D., Ingraham, H. A., Cochet, C., Walton, G. M., Lazar, C. S., Sowadski, J. M., Rosenfeld, M. G., and Gill, G. N. (1991).J. Biol. Chem. 266, 5750–5755.
DiFiore, P. P., Pierce, J. H., Krauss, M. H., Segatto, O., King, C. R., and Aaronson, S. A. (1987).Science 237, 178–182.
Garnier, N., Genest, D., Hebert, E., and Genest, M. (1994).J. Biomol. Struct. Dyn. 11, 983–1002.
Gullick, W. J., and Venter, D. J. (1989). InThe Molecular Biology of Cancer (Waxman, J., and Sikora, K., eds), Blackwells, Oxford, pp. 38–53.
King, C. R., Krauss, M. H., DiFlore, P. P., Paik, S., and Kasprzyk, P. G. (1990).Sem. Cancer Biol. 1, 329–337.
Kynast, B., Binder, L., Marx, D., Zoll, B., Schmoll, H. J., Oellerich, M., and Schauer, A. (1993).J. Cancer Res. Clin. Oncol. 119, 249–252.
Lemoine, N. R., Staddon, S., Dickson, C., Barnes, D. M., and Gullick, W. J. (1990).Oncogene 5, 237–239.
Nemethy, G., Pottle, M. S., and Scheraga, H. A. (1983).J. Phys. Chem. 87, 1883–1887.
Nemethy, G., Gibson, K. D., Palmer, K. A., Yoon, C. N., Paterlini, G., Zagari, A., Rumsey, S., and Scheraga, H. A. (1992).J. Phys. Chem. 96, 6472–6484.
Pincus, M. R. (1988).Int. J. Quantum Chem. Quantum Biol. Symp. 15, 209–220.
Pincus, M. R. (1992).Biopolymers 32, 347–351.
Pincus, M. R., Chung, D., Dykes, D. C., Brandt-Rauf, P. W., Weinstein, I. B., Yamaizumi, Z., and Nishimura, S. (1992).Ann Clin. Lab. Sci. 22, 323–342.
Scheraga, H. A. (1989).Chem. Scripta 29A, 3–13.
Shah, D., Chen, J. M., Carty, R. P., Pincus, M. R., and Scheraga, H. A. (1989).Int. J. Peptide Protein Res. 34, 325–332.
Sternberg, M. J. E., and Gullick, W. J. (1989).Nature 339, 587.
Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Grey, A., Tam, A. W., Lee, J., Yarden, Y., Liberman, T. A., Schlessinger, J., Downword, J., Mayes, E. L. V., Whittle, N., Waterfield, M. D., and Seeburg, P. H. (1984).Nature 309, 418–425.
Vasquez, M., Nemethy, G., and Scheraga, H. A. (1983).Macromolecules 16, 1043–1049.
Yamomoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. (1986).Nature 319, 230–234.
Yarden, Y. (1990).Proc. Natl. Acad. Sci. USA 87, 2569–2573.
Yarden, Y., and Ullrich, A. (1988).Annu. Rev. Biochem. 57, 443–478.
Zimmerman, S. S., Pottle, M. S., Nemethy, G., and Scheraga, H. A. (1977).Macromolecules 10, 1–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brandt-Rauf, P.W., Pincus, M.R. & Monaco, R. Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states. J Protein Chem 14, 33–40 (1995). https://doi.org/10.1007/BF01902842
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01902842